	Alcohol induces sorafenib resistance in hepatocellular carcinoma: A translational study. J Mol Med (Berl) Courtois A, Marié C, Fouquet G, Diouf M, Esparteiro D, Ducournau G, Marticho L, Naassila M, Nguyen-Khac E, Marcq I. PMID: 41580527 [PubMed - indexed for MEDLINE]
	Past, present, and future of immunotherapy research in liver neoplasms: A bibliometric and visualization analysis. Medicine (Baltimore) Ma W, Wang L, Niu Y, Nie Z. PMID: 41578598 [PubMed - indexed for MEDLINE]
	Ferroptosis-related gene signature predicts prognosis and immunotherapy response in hepatocellular carcinoma: A multi-cohort retrospective study. Medicine (Baltimore) Li L, Pang J, Chen J, Pan Y, Liang L, Bai X, He Y, Yang H. PMID: 41578512 [PubMed - indexed for MEDLINE]
	Individualized treatment strategies for primary hepatic neuroendocrine carcinoma: Two case reports and literature review (A CARE-compliant case report). Medicine (Baltimore) Hu H, Chen K, Xiao H, Lan X. PMID: 41578491 [PubMed - indexed for MEDLINE]
	Integrating plasma proteomes with genome-wide association data for causal protein identification in hepatocellular carcinoma: A bidirectional Mendelian randomization study. Medicine (Baltimore) Chen X, Zheng Z, Hu J, Ye S, Liu K. PMID: 41578465 [PubMed - indexed for MEDLINE]
	Impact of cardiometabolic risk factors on hepatocellular carcinoma incidence in patients with chronic hepatitis B: A retrospective cohort study. PLoS One Toh C, Sanit K, Sripongpun P, Chamroonkul N, Liangpunsakul S, Piratvisuth T, Kaewdech A. PMID: 41575955 [PubMed - indexed for MEDLINE]
	Risk Model for Predicting Aggressive Recurrence of Hepatocellular Carcinoma after Microwave Ablation Using MRI and Clinical Parameters. Radiol Imaging Cancer Wei R, Zuo M, Li W, Liu W, Li C, An C. PMID: 41575342 [PubMed - indexed for MEDLINE]
	Gadoxetic Acid-enhanced MRI Radiomics Features of Tumor Margins for Predicting High-Risk Solitary Hepatocellular Carcinoma Aggressiveness and Prognosis. Radiol Imaging Cancer Yu C, Wang X, Tang S, Li Y, Han S, Zhang Q, Qu J, Xu H, Zhou Y. PMID: 41575341 [PubMed - indexed for MEDLINE]
	Survival Benefit and Safety of Anatomic Resection in Cirrhotic Hepatocellular Carcinoma: Propensity-Matched Analysis of 1699 Patients. Cancer Med Du A, Xu H, Jiang C, Yuan K. PMID: 41574643 [PubMed - indexed for MEDLINE]
	Elevated Liver Enzymes and Genotype I of T. gondii Among Liver Cancer Patients: Evidence of a Potential Link. Asian Pac J Cancer Prev Jasim NH, Al-Waaly ABM. PMID: 41569205 [PubMed - indexed for MEDLINE]
	Identification of Extrachromosomal Circular DNA Isolated from Cell Culture Supernatant and Its Potential Applications for Hepatocellular Carcinoma Diagnosis. Asian Pac J Cancer Prev Sukthaworn S, Ondee S, Choksupmanee O, Taengchaiyaphum S, Yodsawat P, Sathapondecha P. PMID: 41569176 [PubMed - indexed for MEDLINE]
	Advancing Diagnostic Accuracy in Liver Cancer: A Systematic Review of Artificial Intelligence Applications in Hepatocellular Carcinoma and Cholangiocarcinoma Detection Using Abdominal CT Imaging. Asian Pac J Cancer Prev Rattanapitoon SK, Arunsarn P, Meererksom T, Thanchonnang C, Boonsuya A, Phinsiri S, Nomsungnoen P, Pongseeda P, Keeratibharat N, Chansangrat J, Pechdee P, Rattanapitoon NK. PMID: 41569166 [PubMed - indexed for MEDLINE]
	Hepatocellular Carcinoma in Pacific Islanders vs. Whites. Hawaii J Health Soc Welf Yee SK, Wong LL. PMID: 41567656 [PubMed - indexed for MEDLINE]
	Exosomal crosstalk: the metastatic language of hepatocellular carcinoma. Front Immunol Xu Q, Chen J, Liu Y, Yu J, Zhao F, Shu Q. PMID: 41567219 [PubMed - indexed for MEDLINE]
	Lenvatinib plus transarterial chemoembolization and PD-1 inhibitors as conversion therapies for unresectable intermediate-advanced hepatocellular carcinoma: a phase 2 trial and exploratory biomolecular study. Signal Transduct Target Ther Zhang X, Cai H, Peng W, Wang H, Wu J, Zhu X, Guo W, Xie F, Zhang Y, Wang M, Yu Y, Zhou Y, Li C, Shen J, Liu C, Yang Y, Jiang X, Li Q, Chen W, Shi Y, Lu W, Sun X, Feng X, Yan M, Cheng S, Wen T. PMID: 41565617 [PubMed - indexed for MEDLINE]
	Prognostic role of tumour volume and downstaging response on outcome after liver transplantation for colorectal liver metastases: retrospective study. BJS Open Jenssen HB, Dueland S, Smedman TM, Grut H, Abildgaard A, Line PD, Syversveen T. PMID: 41564012 [PubMed - indexed for MEDLINE]
	Thioredoxin-Binding protein 2 and apoptosis Signal-Regulating kinase 1: redox stress sensors and therapeutic targets in hepatocellular carcinoma. Med Oncol Afroz N, Ahmad A, Vafa A, Ghosh R, Wajid S. PMID: 41563678 [PubMed - indexed for MEDLINE]
	Serum magnesium predictive value in hepatocellular carcinoma patients on first-line immunotherapy: a retrospective study. Front Immunol Cheng X, Wang W, Xue YN, Tang HL, Li D. PMID: 41562087 [PubMed - indexed for MEDLINE]
	DNAJB6 as an immuno-oncogenic hub in liver hepatocellular carcinoma: multi-omic profiling reveals prognostic significance and therapeutic vulnerability. J Mol Histol Deng Y, Li J, Wang P, Luo X, Xu H, Xiao Y, Wang Z, Lu Y, Chen Y, Ge F. PMID: 41559348 [PubMed - indexed for MEDLINE]
	Clinical Course and Risk Factors of Lenvatinib-Related Hypothyroidism in Hepatocellular Carcinoma: A Retrospective Cohort Study. Cancer Rep (Hoboken) Shiraishi C, Kato H, Asai Y, Iwamoto T. PMID: 41559002 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 74990

Page 1 of 3750



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy